Teruhisa Fujii

9PUBLICATIONS
13CO-AUTHORS
Epidemiological modellingExercise physiologyPacific Peoples cultural determinants of healthHaematologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2026
Five-Year Longitudinal Changes in Treatment Strategies and Clinical Outcomes in Adults With Haemophilia: The ADVANCE Japan Cohort Study.

|Jun 19, 2025
TSUBASA Study: Evaluating Association of Physical Activity and Bleeding Events in People With Haemophilia A Without Factor VIII Inhibitors Receiving Emicizumab.

Kagehiro Amano, Teruhisa Fujii, Akihiro Sawada

|May 02, 2024
Preference of treatment characteristics among people with haemophilia or their caregivers, and physicians in the Japanese healthcare environment.

Teruhisa Fujii, Masataka Ishimura, Satomi Takao

|Jan 31, 2024
Safety of recombinant activated factor VII for treatment of breakthrough bleeds in patients with congenital haemophilia A and inhibitors receiving emicizumab prophylaxis: Review of the real-world evidence.

Gili Kenet, Teruhisa Fujii

|Oct 08, 2023
Haemophilia and cardiovascular disease in Japan: Low incidence rates from ADVANCE Japan baseline data.

Azusa Nagao, Yushi Chikasawa, Akihiro Sawada

|Nov 11, 2016
Analysis of the Japanese subgroup in LEOPOLD II: a phase 2/3 study of BAY 81-8973, a new recombinant factor VIII product.

Teruhisa Fujii, Hideji Hanabusa, Midori Shima

Pageof 2

Frequent Collaborators

3 joint publications

Azusa Nagao

2 joint publications

Tomie Fujii

1 joint publications

Hideyuki Takedani

1 joint publications

Yushi Chikasawa